withdrawal

High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder

Citation
Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128
Publication Date

Abstract

Importance: Emergency departments (EDs) sporadically use a high-dose buprenorphine induction strategy for the treatment of opioid use disorder (OUD) in response to the increasing potency of the illicit opioid drug supply and commonly encountered delays in access to follow-up care.

Rapid Access to Addiction Medicine and Withdrawal Options

Created by
CCSA

 

This webinar explored underlying issues with substance use disorders and helped attendees to understand their complexity and treatment from an evidence-based lens. It also focused on the impacts of COVID-19, withdrawal considerations and advancements in the delivery of care during these uncertain times, including the Rapid Access to Addiction Medicine model.

The ASAM Alcohol Withdrawal Management Webinar Series - Fundamentals

Webinar,

Alcohol is responsible for a multitude of health conditions, including Alcohol Withdrawal Syndrome (AWS). While frequently presented in specialty addiction treatment settings, patients experiencing or at risk for developing AWS also receive care in hospitals, emergency departments, and primary care settings. The current management of patients with AWS is inconsistent across care settings and evidence-based care is often not provided.